Klindamicin Kalceks

Clindamycin, the active ingredient in Klindamicin Kalceks, is a lincosamide antibiotic presented as an injectable solution for intramuscular and intravenous use. It treats a range of bacterial infections, including skin, bone, joint, and intra‑abdominal infections, in adult and pediatric patients as prescribed by a healthcare professional.

GNH USA supplies Klindamicin Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Clindamycin is a lincosamide antibiotic used to treat infections caused by susceptible bacteria. - Skin and soft tissue infections: helps eradicate the causative organisms and promotes healing. - Bone and joint infections: targets bacterial pathogens in osteomyelitis and septic arthritis. - Intra‑abdominal infections: effective against anaerobic and mixed flora in peritonitis and related conditions. - General bacterial infections: used for a variety of serious infections where other agents may be unsuitable.

Clindamycin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Abdominal pain: cramping or discomfort. - Rash: skin erythema or pruritus. - Injection site pain: local tenderness or erythema. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis: severe diarrhea with potential for pseudomembranous colitis. - Anaphylaxis: rapid onset of allergic reaction, including airway compromise. - Hepatotoxicity: elevated liver enzymes or jaundice. - Neutropenia: reduced white blood cell count increasing infection risk. - Stevens‑Johnson syndrome: severe mucocutaneous reaction. - Pseudomembranous colitis: inflammation of the colon due to toxin‑producing bacteria.

Clindamycin requires careful consideration of patient‑specific factors before use. - Renal impairment: dose adjustment may be needed as prescribed. - Hepatic impairment: monitor liver function tests during therapy. - History of colitis: avoid use due to risk of recurrence. - Pregnancy: only if benefits outweigh potential risks; consult obstetrician. - Concurrent antibiotic therapy: assess for antagonistic interactions. - Store below 25°C: keep in original container, protect from moisture and light.

Clindamycin can interact with several medicines, necessitating monitoring.

Major Interactions (Avoid): - Erythromycin: may produce antagonistic effects reducing efficacy. - Lincomycin: additive toxicity, especially hepatotoxicity. - Neuromuscular blocking agents: may potentiate neuromuscular blockade.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - CYP3A4 inhibitors (e.g., ketoconazole): may increase clindamycin plasma levels. - Proton pump inhibitors: may affect absorption and gastric pH.